Dr. Rocci, MD, PhD, serves as TFS’ Medical Scientific Advisor in Oncology since 2020.
Dr Alberto Rocci is a Consultant Hematologist and Multiple Myeloma lead at Manchester University NHS Foundation TRUST (Manchester, UK) as well as Honorary Senior Lecturer at University of Manchester. He received his training in hematology at the University of Turin (Italy) and completed a post-doctoral fellowship at the Ohio State University in Columbus (Ohio, US). He also holds a PhD in Experimental Medicine and Therapy from the University of Turin (Italy).
Dr Rocci’s clinical activity is focused on treating patients with hematological malignancies, in particular those affected by multiple myeloma. His research interests span from translational projects to identify new prognostic biomarkers and targets for novel therapy, to clinical trials incorporating new non-chemotherapeutic agents. He published 40 papers in peer-reviewed international journals and is actively involved in several national and international clinical trials.